Search clinical trials for: ONO-2910

Total 12433 results

Ono Pharmaceutical Co. Ltd

Completed

Single and Multiple Ascending Dose Study to Assess the Safety, Tolerability and PK of ONO-2910 in Japanese and Caucasian Subjects

Healthy Volunteers

Japan
FA Corporation
University of Texas Southwestern Medical Center

Enrolling by invitation

Histological Study of the Effects of a 2910 nm Fiber Laser Technology

Skin Laxity

United States
LEO Pharma

Terminated

Safety, Tolerability and Pharmacokinetics of LEO 29102 Cream in Atopic Dermatitis.

Atopic Dermatitis

Germany
Guangdong Hengrui Pharmaceutical Co., Ltd

Completed

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics Pharmacodynamics of SHR-2010 by Intravenously/Subcutaneously in Healthy Subject

IgA Nephropathy

China
LEO Pharma

Completed

A Safety, Tolerability and Pharmacokinetic Study of LEO 29102 in Subjects With Atopic Dermatitis

Atopic Dermatitis

Netherlands
Alma Lasers Inc.

Unknown

Epidermal Delivery of Ani-Aging Ingredients

Acne Scars | Wrinkles | Pigmentation

United States
LEO Pharma

Completed

LEO 29102 Single and Multiple Dose Study by Dermal Application

Atopic Dermatitis

United Kingdom
Mitsubishi Tanabe Pharma America Inc.

Completed

Safety and Efficacy Study of MT-2990 in Women With Endometriosis

Endometrial Related Pain

United States
Mitsubishi Tanabe Pharma Corporation

Completed

A Clinical Study to Investigate How Safe and Tolerable the Study Drug MT-2990 is and How MT-2990 is Taken up by the Body in Healthy Volunteers

Healthy

Netherlands
LEO Pharma

Completed

Assessment of the Phototoxic Potential of LEO 29102 Cream

Atopic Dermatitis

France
Celgene

Completed

A Study to Assess the Pharmacokinetics of Enasidenib (CC-90007) in Subjects With Moderate and Severe Hepatic Impairment.

Hepatic Impairment

United States
LEO Pharma

Completed

Safety, Tolerability and Pharmacokinetic Study in Healthy Subjects by Dermal Application of a LEO 29102

Atopic Dermatitis

United Kingdom
Celgene

Completed

Pharmacokinetics of Enasidenib (CC-90007) in Participants With Mild, Moderate and Severe Hepatic Impairment

Hepatic Impairment

United States
Assiut University

Not yet recruiting

Renal Resistive Index as a Predictor of Renal Involvement in Rheumatoid Arthritis

Rheumatoid Arthritis
The Medicines Company

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MDCO-2010 in Patients Undergoing Elective Coronary Artery Bypass Graft Surgery

Cardiopulmonary Bypass | Coronary Artery Bypass Graft
Praxisverbund Dialyse und Apherese

Completed

Investigation of Performance and Compatibility of the Baxter Dialyzer Xenium XPH 210 During On-line Hemodiafiltration

End Stage Kidney Disease

Germany
Beth Israel Deaconess Medical Center
Sciton

Active, not recruiting

Laser Treatment for Vulvar Lichen Sclerosus

Vulvar Lichen Sclerosus

United States
Shire

Completed

A Study to Determine the Bioavailability of Lanadelumab (SHP643) Administered Subcutaneously With the Prefilled Syringe and the Autoinjector in Healthy Adult Volunteer Participants.

Healthy Volunteers

United States
BeiGene

Completed

Phase 1a/1b BGB-290 for Advanced Solid Tumors.

For Participants With Advanced Solid Tumors Failed With Previous Lines of Treatment

Australia
Shire

Active, not recruiting

Study of Long Term Safety and Clinical Outcomes of Idursulfase IT and Elaprase Treatment in Pediatric Participants Who Have Completed Study HGT-HIT-094

Hunter Syndrome

United States, Spain, Canada, United Kingdom, Mexico, Australia, France
Edwards (Shanghai) Lifesciences Medical Supplies...

Completed

A Retrospective Study to Collect the Data From the Patients Who Had the Perimount Heart Valve Replacement Surgery in China During 2001 to 2007

Mitral Valve or Aortic Valve Replacement

China
University of Aarhus
Aarhus University Hospital; Danish Cancer Society; University of Southern Denmark

Completed

Health and Coping Prior to Ovarian Cancer Surgery

Health and Coping Undergoing Ovarian Cancer Surgery. | Cancer Rehabilitation

Denmark
Shire

Completed

A Study of Lanadelumab to Prevent Hereditary Angioedema (HAE) Attacks in Children (SPRING)

Hereditary Angioedema

United States, Canada, Germany, Hungary, Spain
Gritstone bio, Inc.

Completed

Study of GRT-R910 COVID-19 Boost Vaccine in Healthy Volunteers

COVID-19

United Kingdom
Amgen

Terminated

Study of AMG 910 in Subjects With CLDN18.2-Positive Gastric and Gastroesophageal Junction Adenocarcinoma

Gastric and Gastroesophageal Junction Adenocarcinoma

Korea, Republic of, Taiwan, Spain, Austria, United States, France, Japan, Germany, Netherlands
Pharmazz, Inc.

Not yet recruiting

A Study to Assess Safety and Efficacy of Centhaquine as a Resuscitative Agent

Hypovolemic Shock
Takeda

Available

Post-trial Access Program of Idursulfase-IT Along With Elaprase in Children With Hunter Syndrome

Hunter Syndrome

United States, Australia, Mexico, Spain, United Kingdom
Pharmazz, Inc.

Completed

A Study to Determine the Safety, Tolerability and Pharmacokinetics of PMZ-2010 (Centhaquin) in Healthy Volunteers

Healthy

India
NervGen Pharma

Recruiting

NVG-291 in Spinal Cord Injury Subjects

Spinal Cord Injuries | Chronic Spinal Cord Injury | Subacute Spinal Cord Injury

United States
Mitsubishi Tanabe Pharma Corporation

Recruiting

An Exploratory Study of MT-2990 in Patients With AAV

Antineutrophil Cytoplasmic Antibody (ANCA) -Associated Vasculitis (AAV)

Japan
Pharmazz, Inc.

Not yet recruiting

Multicentric, Randomized Study to Assess Safety and Efficacy of Centhaquine in COVID-19 Patients With ARDS

COVID-19 Acute Respiratory Distress Syndrome
Armgo Pharma, Inc.
National Institute of Nursing Research (NINR); National Institute of Neurological... and other collaborators

Completed

S 48168 (ARM 210) for the Treatment of RYR1-related Myopathies (RYR1-RM)

RYR-1 Myopathy

United States
Vertex Pharmaceuticals Incorporated

Terminated

Study to Assess the Efficacy and Safety of VX-210 in Subjects With Acute Traumatic Cervical Spinal Cord Injury

Cervical Spinal Cord Injury

United States, Canada
Shire
Takeda Development Center Americas, Inc.

Withdrawn

Lanadelumab in Participants Hospitalized With COVID-19 Pneumonia

COVID-19 Pneumonia
International AIDS Vaccine Initiative

Completed

Safety and Immunogenicity Study of SeV-G(NP) HIV Vaccine Administered Intranasally and Ad35-GRIN HIV Vaccine Given Intramuscularly in Prime-Boost Regimens in HIV-Uninfected Volunteers

HIV Infections

United Kingdom, Kenya, Rwanda
Fudan University

Recruiting

Pamiparib for Consolidation Treatment of Unprogressed LS-SCLC After Concurrent Chemoradiotherapy

Limited Stage Small Cell Lung Cancer

China
NervGen Pharma

Completed

A Phase I Safety Study of NVG-291 in Healthy Adults

Spinal Cord Injury

Australia
BeiGene

Terminated

Treatment of Metastatic Castration-Resistant Prostate Cancer With Homologous Recombination Deficiency

Metastatic Castration-Resistant Prostate Cancer (mCRPC) | Homologous Recombination Deficiency (HRD)

United States, Australia, Puerto Rico, Spain
Australia New Zealand Gynaecological Oncology Group
BeiGene

Withdrawn

Pamiparib in Fusion Positive, Reversion Negative High Grade Serous Ovarian Cancer or Carcinosarcoma With BRCA1/2 Gene Mutations If Progression on Substrate Poly ADP Ribose Polymerase Inhibitbor (PARPI) or Chemotherapy (PRECISE)

Ovarian Cancer | Carcinosarcoma
Shire

Completed

A Double-Blind, Multiple Ascending Dose Study to Assess Safety, Tolerability and Pharmacokinetics of DX-2930 in Hereditary Angioedema Participants

Hereditary Angioedema (HAE)

United States, Jordan, Italy
University of Maryland, Baltimore
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Ebola CVD-Mali #2000 (Bivalent) VRC-EBOAdc069-00-vp (cAd3-EBO)

Ebola Virus Disease | Hemorrhagic Fever

Mali
Shire
Dyax Corp.

Completed

Efficacy and Safety Study of DX-2930 to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE

Hereditary Angioedema (HAE)

United States, Canada, Germany, Italy, Jordan, Puerto Rico, United Kingdom
Guangdong Hengrui Pharmaceutical Co., Ltd

Recruiting

Efficacy and Safety of SHR-2010 Injection in the Treatment of Primary IgA Nephropathy

Primary IgA Nephropathy

China
David Scheifele
Canadian Institutes of Health Research (CIHR)

Completed

Rapid Evaluation of Pandemic H1N1 Influenza Vaccine in Adults Receiving Seasonal Influenza Vaccine

Influenza | H1N1 2009 Influenza

Canada
KarmelSonix Ltd.

Unknown

Wheeze Detection in Adults During Dynamic Bronchial Situations Measured by PulmoTrack® 2010 With WIM-PC™ Technologies Recording

Asthma, Bronchial

Israel
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Shanghai Runshi Pharmaceutical Technology Co., Ltd

Recruiting

A Phase I Trial of Simmitinib in Advanced Solid Tumors

Advanced Solid Tumor

China
Mitsubishi Tanabe Pharma Corporation

Completed

A Clinical Pharmacology Study of MT-2990 in Seasonal Allergic Rhinitis Patients

Seasonal Allergic Rhinitis

Japan
University of Oxford
Chittagong Medical College and Hospital

Completed

Study of Body Positions in Unconsciousness

Coma

Bangladesh
The Dial Corporation
TKL Research, Inc.; Hill Top Research

Completed

Efficacy Trial of 3804-250A in the Prevention of Cold Illnesses

Common Cold

United States
Seqirus

Completed

A Study to Assess the Immunogenicity and Safety of CSL's 2009 / 2010 Formulation of Enzira® Vaccine in Healthy Volunteers

Influenza

United Kingdom

3

Subscribe